Molecular markers for the diagnosis of Philadelphia chromosome negative myeloproliferative disorders

Pathologie Biologie

Volumn 52, Issue 5, 2004, Pages 267-274

  Klippel, Steffen ^a   Pahl, Heike L ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

c Mpl; Clonality assays; Endogenous erythroid colonies; Myeloproliferative disorders; PRV 1

Indexed keywords

MESSENGER RNA; MOLECULAR MARKER; THROMBOPOIETIN RECEPTOR;

CLONAL VARIATION; CONFERENCE PAPER; ERYTHROID CELL; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PHILADELPHIA CHROMOSOME NEGATIVE CELL; POLYCYTHEMIA VERA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOTIC THROMBOCYTOPENIC PURPURA;

GENETIC MARKERS; HUMANS; MYELOPROLIFERATIVE DISORDERS; PHILADELPHIA CHROMOSOME;

EID: 3042662518     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2003.09.019     Document Type: Conference Paper

References (77)

1. Dameshek W. Some speculations on the myeloproliferative syndromes. Blood. 6:1951;372-375
2. Nowell P.C., Hungerford D.A. A minute chromosome in human chronic granulocytic leukemia. Science. 132:1960;1497
3. Rowley J.D. A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature. 243:1973;290-293
4. Nowell P.C., Finan J.B. Cytogenetics of acute and chronic myelofibrosis. Virchows Arch B Cell Pathol. 29:(1&2):1978;45-50
5. Westin J., Wahlstrom J., Swolin B. Chromosome studies in untreated polycythaemia vera. Scand J Haematol. 17:(3):1976;183-196
6. Lawler S.D. Cytogenetic studies in Philadelphia chromosome-negative myeloproliferative disorders, particularly polycythaemia rubra vera. Clin Haematol. 9:(1):1980;159-174
7. Diez-Martin J.L., Graham D.L., Petitt R.M., Dewald G.W. Chromosome studies in 104 patients with polycythemia vera. Mayo Clin Proc. 66:(3):1991;287-299
8. Kopf I., Swolin B., Weinfeld A. Cytogenetic studies on primary thrombocythaemia. Hereditas. 97:(2):1982;217-220
9. Carbonell F., Ganser A., Heimpel H. Cytogenetic studies in chronic myeloproliferative disorders. Acta Haematol. 69:(3):1983;145-151
10. Mertens F., Johansson B., Heim S., Kristoffersson U., Mitelman F. Karyotypic patterns in chronic myeloproliferative disorders: report on 74 cases and review of the literature. Leukemia. 5:(3):1991;214-220
11. Wasserman L.R. The management of polycythaemia vera. Br J Haematol. 21:(4):1971;371-376
12. Pearson T.C., Messinezy M. The diagnostic criteria of polycythaemia rubra vera. Leuk Lymphoma. 22:(Suppl 1):1996;87-93
13. Tefferi A. Diagnosing polycythemia vera: a paradigm shift. Mayo Clin Proc. 74:(2):1999;159-162
14. Vardiman JW, Bain B, Brunning RD, et al. Chronic myeloproliferative diseases. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization Classification of Tumours, Pathology & Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC; 2001. p. 16-44.
15. Streiff M.B., Smith B., Spivak J.L. The diagnosis and management of polycythemia vera in the era since the Polycythemia Vera Study Group: a survey of American Society of Hematology members' practice patterns. Blood. 99:(4):2002;1144-1149
16. Johansson P., Andreasson B., Safai-Kutti S., Rhedin C., Vilen L., Vaart J., Kutti J. On the diagnosis of polycythaemia vera as assessed in the health and medical care in the Vastra Gotaland region, Sweden. J Intern Med. 251:(4):2002;348-354
17. Prchal J.F., Axelrad A.A. Bone-marrow responses in polycythemia vera. N Engl J Med. 290:(24):1974;1382
18. Correa P.N., Eskinazi D., Axelrad A.A. Circulating erythroid progenitors in polycythemia vera are hypersensitive to insulin-like growth factor-1 in vitro: studies in an improved serum-free medium. Blood. 83:(1):1994;99-112
19. Adamson J.W. Analysis of myeloproliferative disorders using cell markers in culture. Haematol Blood Transfus. 23:1979;205-210
20. Cashman J., Henkelman D., Humphries K., Eaves C., Eaves A. Individual BFU-E in polycythemia vera produce both erythropoietin dependent and independent progeny. Blood. 61:(5):1983;876-884
21. Carneskog J., Kutti J., Wadenvik H., Lundberg P.A., Lindstedt G. Plasma erythropoietin by high-detectability immunoradiometric assay in untreated and treated patients with polycythaemia vera and essential thrombocythaemia. Eur J Haematol. 60:(5):1998;278-282
22. Messinezy M., Westwood N.B., El-Hemaidi I., Marsden J.T., Sherwood R.S., Pearson T.C. Serum erythropoietin values in erythrocytoses and in primary thrombocythaemia. Br J Haematol. 117:(1):2002;47-53
23. Chiba S., Takahashi T., Takeshita K., Minowada J., Yazaki Y., Ruddle F.H., et al. Selective expression of mRNA coding for the truncated form of erythropoietin receptor in hematopoietic cells and its decrease in patients with polycythemia vera. Blood. 90:(1):1997;97-104
24. Motohashi T., Nakamura Y., Osawa M., Hiroyama T., Iwama A., Shibuya A., et al. Increased cell surface expression of C-terminal truncated erythropoietin receptors in polycythemia. Eur J Haematol. 67:(2):2001;88-93
25. Osawa M., Yamaguchi T., Nakamura Y., Kaneko S., Onodera M., Sawada K., et al. Erythroid expansion mediated by the Gfi-1B zinc finger protein: role in normal hematopoiesis. Blood. 100:(8):2002;2769-2777
26. Eridani S., Pearson T.C., Sawyer B., Batten E., Wetherley-Mein G. Erythroid colony formation in primary proliferative polycythaemia, idiopathic erythrocytosis and secondary polycythaemia: sensitivity to erythropoietic stimulating factors. Clin Lab Haematol. 5:(2):1983;121-129
27. Eridani S., Sawyer B., Pearson T.C. Patterns of in vitro BFU-E proliferation in different forms of polycythaemia and in thrombocythaemia. Eur J Haematol. 38:(4):1987;363-369
28. Shih L.Y., Lee C.T. Identification of masked polycythemia vera from patients with idiopathic marked thrombocytosis by endogenous erythroid colony assay. Blood. 83:(3):1994;744-748
29. Weinberg R.S., Worsley A., Gilbert H.S., Cuttner J., Berk P.D., Alter B.P. Comparison of erythroid progenitor cell growth in vitro in polycythemia vera and chronic myelogenous leukemia: only polycythemia vera has endogenous colonies. Leuk Res. 13:(4):1989;331-338
30. Biljanovic-Paunovic L., Ruvidic R., Pavlovic-Kentera V. Endogenous BFU-E in peripheral blood in diagnosis of polycythemia vera. Eur J Haematol. 45:(5):1990;262-266
31. Masters G.S., Baines P., Jacobs A. Erythroid colony growth from peripheral blood and bone marrow in polycythaemia. J Clin Pathol. 43:(11):1990;937-941
32. Westwood N.B., Pearson T.C. Diagnostic applications of haemopoietic progenitor culture techniques in polycythaemias and thrombocythaemias. Leuk Lymphoma. 22:(Suppl 1):1996;95-103
33. Lutton J.D., Levere R.D. Endogenous erythroid colony formation by peripheral blood mononuclear cells from patients with myelofibrosis and polycythemia vera. Acta Haematol. 62:(2):1979;94-99
34. Liu E., Jelinek J., Pastore Y.D., Guan Y., Prchal J.F., Prchal J.T. Discrimination of polycythemias and thrombocytoses by novel, simple, accurate clonality assays and comparison with PRV-1 expression and BFU-E response to erythropoietin. Blood. 101:(8):2003;3294-3301
35. Kralovics R., Buser A.S., Teo S.S., Coers J., Tichelli A., Van Der Maas A.P., et al. Comparison of molecular markers in a cohort of patients with chronic myeloproliferative disorders. Blood. 2003 May 1;. [Epub ahead of print]
36. Klippel S., Strunck E., Temerinac S., Kralovics R., Prchal J.T., Griesshammer M., et al. Quantification of PRV-1 expression, a molecular marker for the diagnosis of polycythemia vera [abstract]. Blood. 98:(11):2001;470a
37. Brown C.J., Ballabio A., Rupert J.L., Lafreniere R.G., Grompe M., Tonlorenzi R., et al. A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome. Nature. 349:(6304):1991;38-44
38. Adamson J.W., Fialkow P.J., Murphy S., Prchal J.F., Steinmann L. Polycythemia vera: stem-cell and probable clonal origin of the disease. N Engl J Med. 295:(17):1976;913-916
39. Fialkow P.J., Faguet G.B., Jacobson R.J., Vaidya K., Murphy S. Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell. Blood. 58:(5):1981;916-919
40. Raskind W.H., Jacobson R., Murphy S., Adamson J.W., Fialkow P.J. Evidence for the involvement of B lymphoid cells in polycythemia vera and essential thrombocythemia. J Clin Invest. 75:(4):1985;1388-1390
41. Jacobson R.J., Salo A., Fialkow P.J. Agnogenic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosis. Blood. 51:(2):1978;189-194
42. Gale R.E., Wheadon H., Goldstone A.H., Burnett A.K., Linch D.C. Frequency of clonal remission in acute myeloid leukaemia. Lancet. 341:(8838):1993;138-142
43. Fey M.F., Liechti-Gallati S., von Rohr A., Borisch B., Theilkas L., Schneider V., et al. Clonality and X-inactivation patterns in hematopoietic cell populations detected by the highly informative M27 beta DNA probe. Blood. 3:(4):1994;31-38
44. Hendriks R.W., Chen Z.Y., Hinds H., Schuurman R.K., Craig I.W. An X chromosome inactivation assay based on differential methylation of a CpG island coupled to a VNTR polymorphism at the 5′ end of the monoamine oxidase A gene. Hum Mol Genet. 1:(8):1992;662
45. Lee S.T., McGlennen R.C., Litz C.E. Clonal determination by the fragile X (FMR1) and phosphoglycerate kinase (PGK) genes in hematological malignancies. Cancer Res. 54:(19):1994;5212-5216
46. Gale R.E., Mein C.A., Linch D.C. Quantification of X-chromosome inactivation patterns in haematological samples using the DNA PCR-based HUMARA assay. Leukemia. 10:(2):1996;362-367
47. Delabesse E., Aral S., Kamoun P., Varet B., Turhan A.G. Quantitative non-radioactive clonality analysis of human leukemic cells and progenitors using the human androgen receptor (AR). Leukemia. 9:(9):1995;1578-1582
48. Gale R.E. Evaluation of clonality in myeloid stem-cell disorders. Semin Hematol. 36:(4):1999;361-372
49. Puck J.M., Stewart C.C., Nussbaum R.L. Maximum-likelihood analysis of human T-cell X chromosome inactivation patterns: normal women versus carriers of X-linked severe combined immunodeficiency. Am J Hum Genet. 50:(4):1992;742-748
50. Beutler E., Kuhl W. The NT 1311 polymorphism of G6PD: G6PD Mediterranean mutation may have originated independently in Europe and Asia. Am J Hum Genet. 47:(6):1990;1008-1012
51. Hopwood J.J., Bunge S., Morris C.P., Wilson P.J., Steglich C., Beck M., et al. Molecular basis of mucopolysaccharidosis type II: mutations in the iduronate-2-sulphatase gene. Hum Mutat. 2:(6):1993;435-442
52. Luhovy M., Liu Y., Belickova M., Prchal J.F., Prchal J.T. A novel clonality assay based on transcriptional polymorphism of X chromosome gene p55. Biol Blood Marrow Transplant. 1:(2):1995;81-87
53. Liu Y., Phelan J., Go R.C., Prchal J.F., Prchal J.T. Rapid determination of clonality by detection of two closely-linked X chromosome exonic polymorphisms using allele-specific PCR. J Clin Invest. 99:(8):1997;1984-1990
54. el-Kassar N., Hetet G., Briere J., Grandchamp B. Clonality analysis of hematopoiesis in essential thrombocythemia: advantages of studying T lymphocytes and platelets. Blood. 89:(1):1997;128-134
55. Gale R.E., Fielding A.K., Harrison C.N., Linch D.C. Acquired skewing of X-chromosome inactivation patterns in myeloid cells of the elderly suggests stochastic clonal loss with age. Br J Haematol. 98:(3):1997;512-519
56. Busque L., Mio R., Mattioli J., Brais E., Blais N., Lalonde Y., et al. Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age. Blood. 88:(1):1996;59-65
57. Champion K.M., Gilbert J.G., Asimakopoulos F.A., Hinshelwood S., Green A.R. Clonal haemopoiesis in normal elderly women: implications for the myeloproliferative disorders and myelodysplastic syndromes. Br J Haematol. 97:(4):1997;920-926
58. Harrison C.N., Gale R.E., Machin S.J., Linch D.C. A large proportion of patients with a diagnosis of essential thrombocythemia do not have a clonal disorder and may be at lower risk of thrombotic complications. Blood. 93:(2):1999;417-424
59. Moliterno A.R., Hankins W.D., Spivak J.L. Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera. N Engl J Med. 338:(9):1998;572-580
60. Moliterno A.R., Spivak J.L. Posttranslational processing of the thrombopoietin receptor is impaired in polycythemia vera. Blood. 94:(8):1999;2555-2561
61. Moliterno A.R., Williams D.M., Spivak J.L. Enhanced in vitro viability of polycythemia vera CD34+ cells is associated with abnormal thrombopoietin receptor expression and aberrant signal transduction. Blood. 98:2001;1961a
62. Moliterno A.R., Silver R.T., Spivak J.L. A diagnostic assay for polycythemia vera. Blood. 96:2000;512a
63. Tefferi A., Yoon S.Y., Li C.Y. Immunohistochemical staining for megakaryocyte c-mpl may complement morphologic distinction between polycythemia vera and secondary erythrocytosis. Blood. 96:(2):2000;771-772
64. Teofili L., Pierconti F., Di Febo A., Maggiano N., Vianelli N., Ascani S., et al. The expression pattern of c-mpl in megakaryocytes correlates with thrombotic risk in essential thrombocythemia. Blood. 100:(2):2002;714-717
65. Horikawa Y., Matsumura I., Hashimoto K., Shiraga M., Kosugi S., Tadokoro S., et al. Markedly reduced expression of platelet c-mpl receptor in essential thrombocythemia. Blood. 90:(10):1997;4031-4038
66. Harrison C.N., Gale R.E., Pezella F., Mire-Sluis A., MacHin S.J., Linch D.C. Platelet c-mpl expression is dysregulated in patients with essential thrombocythaemia but this is not of diagnostic value. Br J Haematol. 107:(1):1999;139-147
67. Temerinac S., Klippel S., Strunck E., Roder S., Lubbert M., Lange W., et al. Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera. Blood. 95:(8):2000;2569-2576
68. Klippel S., Strunck E., Busse C.E., Behringer D., Pahl H.L. Biochemical characterization of PRV-1, a novel hematopoietic cell surface receptor, which is overexpressed in polycythemia rubra vera. Blood. 100:(7):2002;2441-2448
69. Teofili L., Martini M., Luongo M., Di Mario A., Leone G., De Stefano V., et al. Overexpression of the polycythemia rubra vera-1 gene in essential thrombocythemia. J Clin Oncol. 20:(20):2002;4249-4254
70. Klippel S., Strunck E., Temerinac S., Bench A.J., Meinhardt G., Mohr U., et al. Quantification of PRV-1 mRNA distinguishes Polycythemia vera from secondary. Blood. 2003;. Jul 31[Epub ahead of print]
71. Fruehauf S., Topaly J., Villalobos M., Veldwijk M.R., Laufs S., Ho A.D. Quantitative real-time polymerase chain reaction shows that treatment with interferon reduces the initially upregulated PRV-1 expression in polycythemia vera. Haematologica. 88:(3):2003;349-351
72. Bux J., Goehring K., Wolff J., Kissel K., Doppl W., Schmidt K.L., et al. Expression of NB1 Glycoprotein (HNA-2A, CD177) on neutrophils is upregulated in inflammatory diseases and during G-CSF treatment [abstract]. Blood. 100:(11):2002;462-463a
73. Spinelli O., Rota B., Finazzi G., Barbui T. Quantitative PCR analysis of PRV-1 expression in chronic myeloproliferative disorders: positive correlation with polycythemia vera diagnosis and leukocyte alkaline phosphatase expression [abstract]. Blood. 100:(11):2002;796a
74. Ricksten A., Palmquist L., Wasslavik C., Johansson P., Andreasson B., Safai-Kutti S., et al. High PRV-1 mRNA expression, a diagnostic marker for PV [abstract]. Blood. 100:(11):2002;799a
75. Johansson P., Andreasson B., Safai-Kutti S., Wennstrom L., Palmqvist L., Ricksten A., et al. The presence of a significant association between elevated PRV-1 mRNA expression and low plasma erythropoietin concentration in essential thrombocythaemia. Eur J Haematol. 70:(6):2003;358-362
76. Brohée D., Vanuffel P., Ravoet C., Mineur P., Vandingenen T., Maerevoet M., et al. Correlation of PRV-1 expression with clinical diagnosis in myeloproliferative syndromes [abstract]. Blood. 100:(11):2002;796-797a
77. Raaijmakers M.H., van Emst L., de Witte T., Mensink E., Raymakers R.A. Quantitative assessment of gene expression in highly purified hematopoietic cells using real-time reverse transcriptase polymerase chain. Exp Hematol. 30:(5):2002;481-487